Career & Filing History
Every role John T. Treace has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
John T. Treace serves as Chief Executive Officer of TREACE MEDICAL CONCEPTS, INC. (TMCI). Treace has reported 9 insider filings with the SEC since 2026. The most recent filing was in August 2026.
Every role John T. Treace has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
TREACE MEDICAL CONCEPTS, INC. (TMCI)4 filingsUpdated Aug 31, 2026
John T. Treace is Chief Executive Officer, Director, 10% Owner of TREACE MEDICAL CONCEPTS, INC. (TMCI). 9 SEC Form 4 filings on record, most recently on 24 August 2026. Most recent open-market trade: bought $48K of TMCI on 24 August 2026. Lifetime open-market purchases: $1.45M. Historical track record: 5/5 stars across 4 tracked purchases.
Every recent SEC Form 4 transaction John T. Treace has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 100% |
| 90-day win rate | 100% |
| Avg 5-day return | +13.48% |
| Avg 30-day return | +57.40% |
| Avg 90-day return | +79.18% |
| Best 30-day return |
InsiderAlpha's records for John T. Treace go back to 2026: 9 primary Form 4 filings, an average of 9.0 per year. The typical open-market purchase is $104K (14 buys totaling $1.45M). The largest single buy on record is $185K of TMCI in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
No other insider has filed at John T. Treace's companies, so these are insiders reporting open-market trades at other companies in the same sector.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
John T. Treace is a corporate insider, tracked as Chief Executive Officer, Director, 10% Owner of TREACE MEDICAL CONCEPTS, INC. (TMCI). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 14 open-market purchases ($1.45M) and 0 open-market sales across all tracked filings.
Across 4 tracked purchases, John T. Treace averaged +57.4% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$TMCI TREACE MEDICAL CONCEPTS, INC.39.9K shares @ $4.44$177K
| +70.37% |